Medical Devices

A California clinic known for ketamine bets on the booming NAD+ IV market. As wellness clinics expand, experts question if the science supports the high price tag.

A new partnership between Pirche and Natera promises to connect pre-transplant risk analysis with post-transplant monitoring, ushering in an era of truly personalized care.

Canada leverages Europe's top tech event to advance its new national AI strategy, seeking to build a 'trustworthy AI' bloc and secure global market share.

Straive's acquisition of NextGen Invent isn't just another deal; it's a strategic strike to dominate the AI operationalization market. Here's why.

A major partnership in Michigan and Ohio's ENT sector signals a growing trend: private equity-backed groups are reshaping independent medical practices.

uniQure's early trial data for AMT-260 shows promise in reducing severe seizures, but experts urge cautious optimism on the long road to a cure.

For many rural families, a child's heart defect was a death sentence. Now, a coal company's ambitious CSR program is rewriting their future, one tiny heart at a time.

A new campaign reveals a public health crisis of 'eye anxiety.' But behind the celebrity endorsement lies a sharp strategy to vertically integrate and capture the market.

Beyond deep discounts, COSRX's Amazon Prime Day offensive reveals a masterclass in digital strategy, leveraging viral products to dominate Europe's beauty market.

South Korean brand Lactomedi’s nationwide CVS launch signals a major shift in feminine care, blending K-Beauty innovation with advanced microbiome science.

South Korea's Wellness Innercell targets Indonesia's booming wellness market. Its Surabaya-first strategy reveals a calculated blueprint for navigating Southeast Asia.

Align Technology names Exact Sciences veteran Kevin Conroy its next Chairman, a strategic move signaling a new chapter of growth and innovation in digital dentistry.

CosmoFarm hits a $60M run-rate with advanced robotics, but its record growth is set against the backdrop of parent Cosmos Health's 'going concern' warning.

AdventHealth is pouring $214M into its Carrollwood hospital. It's not just a local expansion—it's a strategic move in a high-stakes race to serve Florida's boom.

With a new Deputy CEO and a shift for its COO, Exor is fortifying its core while positioning its fast-growing investment arm, Lingotto, for the future.

A scientific shift from replacement to regeneration is fueling a market set to surpass $100B. But can new players navigate the regulatory and commercial hurdles?

An independent study reveals a Quebec-based platform dramatically improves patient outcomes and slashes clinical workload. Is this the new OS for healthcare?

For decades, insomnia treatment meant risky sedatives. Now, a new class of drugs is revolutionizing sleep science, promising safer rest for millions.

Life science labs are eagerly exploring AI, but new data reveals a major roadblock: a fragmented digital landscape that keeps true innovation just out of reach.

A new alliance aims to get an FDA-cleared device for a painful chemo side effect into patients' hands, tackling the hidden barriers of healthcare logistics.